CD2 expression in CD56dimCD16− NK cells is reduced in moderate CFS/ME patients compared with severely affected patients, suggesting that these cells may have an impaired ability to adhere to target cells. The gene discussed is CD2; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.